ReGeneraTing Agents (RGTA®) technology combined with antibiotics improves outcomes for infections in the upper limb

Abstract

In this case series, four patients developed or presented with severe infections. In addition to antimicrobial therapy, they were treated with a new matrix therapy technology called CACIPLIQ20®. CACIPLIQ20® markedly improved the outcomes of all cases in terms of healing times and range of motion despite healing by secondary intention.